Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product -- Ignore unavailable to you. Want to Upgrade?

To: vestor who wrote (646)	3/12/1998 7:49:00 AM
From: Thure Meyer	Read Replies (3) \| Respond to of 1837

Vestor, Although I am optimistic that Duramed will get their product approved, its not a shoo in. I spent last night looking through all the public FDA docs on Premarin, conjugated estrogen, etc. There has been fundamental resistance to this. The argument centers around what constitutes a generic alternative and there the discussion is about which compounds are active and so on. How much of this is real and how much is political is difficult to assay, but I am sure that AHP will be in there kicking and screaming to keep their market. Thure